作者
Ravi Jasuja,Karol M. Pencina,Daniel J. Spencer,Liming Peng,Fabiola Privat,Waljit S. Dhillo,Channa N. Jayasena,Frances J. Hayes,Bu B. Yeap,Alvin M. Matsumoto,Shalender Bhasin
摘要
Abstract Background Free testosterone (FT) determination may be helpful in evaluating men suspected of testosterone deficiency especially in conditions with altered binding‐protein concentrations. However, methods for measuring FT by equilibrium dialysis and reference intervals vary among laboratories. Objective To determine reference intervals for FT in healthy, nonobese men by age groups as well as in healthy young men, 19–39 years, using a standardized equilibrium dialysis procedure Methods We measured FT in 145 healthy, nonobese men, 19 years or older, using a standardized equilibrium dialysis method performed for 16‐h at 37°C using undiluted serum and dialysis buffer that mimicked the ionic composition of human plasma. FT in dialysate was measured using a CDC‐certified liquid chromatography tandem mass spectrometry assay. Results In healthy nonobese men, the 2.5th, 10th, 50th, 90th, and 97.5th percentile values for FT were 66, 91, 141, 240, and 309 pg/ml, respectively; corresponding values for men, 19–39 years, were 120, 128, 190, 274, and 368 pg/ml, respectively. FT levels by age groups exhibit the expected age‐related decline. FT levels were negatively associated with body mass index, age, and sex hormone‐binding globulin (SHBG) levels. Percent FT was lower in middle‐aged and older men than young men adjusting for SHBG level. Discussion Further studies are needed to determine how these reference intervals apply to the diagnosis of androgen deficiency in clinical populations and in men of different races and ethnicities in different geographic regions. Conclusion Reference intervals for free FT levels (normative range 66–309 pg/ml [229–1072 pmol/L] in all men and 120–368 pg/ml [415–1274 pmol/L] in men, 19–39 years), measured using a standardized equilibrium dialysis method in healthy nonobese men, provide a rational basis for categorizing FT levels. These intervals require further validation in other populations, in relation to outcomes, and in randomized trials.